Cargando…

A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis

OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Kengo, Hiyoshi, Masahide, Imamura, Naoya, Hamada, Takeomi, Yano, Koichi, Sato, Yuichiro, Sakae, Takehumi, Komi, Masanori, Nakamura, Takashi, Choijookhuu, Narantsog, Hishikawa, Yoshitaka, Nanashima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183286/
https://www.ncbi.nlm.nih.gov/pubmed/37062714
http://dx.doi.org/10.2169/internalmedicine.0410-22
_version_ 1785041923860332544
author Kai, Kengo
Hiyoshi, Masahide
Imamura, Naoya
Hamada, Takeomi
Yano, Koichi
Sato, Yuichiro
Sakae, Takehumi
Komi, Masanori
Nakamura, Takashi
Choijookhuu, Narantsog
Hishikawa, Yoshitaka
Nanashima, Atsushi
author_facet Kai, Kengo
Hiyoshi, Masahide
Imamura, Naoya
Hamada, Takeomi
Yano, Koichi
Sato, Yuichiro
Sakae, Takehumi
Komi, Masanori
Nakamura, Takashi
Choijookhuu, Narantsog
Hishikawa, Yoshitaka
Nanashima, Atsushi
author_sort Kai, Kengo
collection PubMed
description OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for diagnosing pancreatic fibrosis and the appropriate imaging condition as the “equilibrium phase”. METHODS: In 27 patients undergoing multiphasic CT and subsequent pancreaticoduodenectomy, we investigated pathological fibrotic changes related to the ECV fraction and conducted analyses using the value obtained by subtracting the equilibrium CT value of the portal vein from that of the abdominal aorta (Ao-PV(equilibrium)) to estimate eligibility of the equilibrium phase. RESULTS: In all patients, the ECV fraction showed a weak positive correlation with the collagenous compartment ratio (r=0.388, p=0.045). All patients were divided into two groups - the high-Ao-PV(equilibrium) group and low-Ao-PV(equilibrium) group - based on the median value. No significant correlation was found in the high-Ao-PV(equilibrium) group, whereas a significant correlation was observed in the low-Ao-PV(equilibrium) group (r=0.566, p=0.035). CONCLUSION: The ECV fraction is a possible predictive factor for histopathological pancreatic fibrosis. In its clinical application, the eligibility of the “equilibrium phase” may affect the diagnostic capability. It will be necessary to verify the imaging conditions in order to improve the accuracy of the diagnosis.
format Online
Article
Text
id pubmed-10183286
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-101832862023-05-15 A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis Kai, Kengo Hiyoshi, Masahide Imamura, Naoya Hamada, Takeomi Yano, Koichi Sato, Yuichiro Sakae, Takehumi Komi, Masanori Nakamura, Takashi Choijookhuu, Narantsog Hishikawa, Yoshitaka Nanashima, Atsushi Intern Med Original Article OBJECTIVE: The extracellular volume (ECV) calculated based on contrast-enhanced computed tomography (CT) has been reported as a novel imaging parameter reflecting the morphological change of fibrosis in several parenchymal organs. Our retrospective study assessed the validity of the ECV fraction for diagnosing pancreatic fibrosis and the appropriate imaging condition as the “equilibrium phase”. METHODS: In 27 patients undergoing multiphasic CT and subsequent pancreaticoduodenectomy, we investigated pathological fibrotic changes related to the ECV fraction and conducted analyses using the value obtained by subtracting the equilibrium CT value of the portal vein from that of the abdominal aorta (Ao-PV(equilibrium)) to estimate eligibility of the equilibrium phase. RESULTS: In all patients, the ECV fraction showed a weak positive correlation with the collagenous compartment ratio (r=0.388, p=0.045). All patients were divided into two groups - the high-Ao-PV(equilibrium) group and low-Ao-PV(equilibrium) group - based on the median value. No significant correlation was found in the high-Ao-PV(equilibrium) group, whereas a significant correlation was observed in the low-Ao-PV(equilibrium) group (r=0.566, p=0.035). CONCLUSION: The ECV fraction is a possible predictive factor for histopathological pancreatic fibrosis. In its clinical application, the eligibility of the “equilibrium phase” may affect the diagnostic capability. It will be necessary to verify the imaging conditions in order to improve the accuracy of the diagnosis. The Japanese Society of Internal Medicine 2022-04-15 2023-04-15 /pmc/articles/PMC10183286/ /pubmed/37062714 http://dx.doi.org/10.2169/internalmedicine.0410-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Kai, Kengo
Hiyoshi, Masahide
Imamura, Naoya
Hamada, Takeomi
Yano, Koichi
Sato, Yuichiro
Sakae, Takehumi
Komi, Masanori
Nakamura, Takashi
Choijookhuu, Narantsog
Hishikawa, Yoshitaka
Nanashima, Atsushi
A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title_full A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title_fullStr A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title_full_unstemmed A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title_short A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis
title_sort preliminary pathological evaluation of extracellular volume fraction with contrast-enhanced computed tomography as a novel quantitative parameter of pancreatic fibrosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183286/
https://www.ncbi.nlm.nih.gov/pubmed/37062714
http://dx.doi.org/10.2169/internalmedicine.0410-22
work_keys_str_mv AT kaikengo apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hiyoshimasahide apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT imamuranaoya apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hamadatakeomi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT yanokoichi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT satoyuichiro apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT sakaetakehumi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT komimasanori apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT nakamuratakashi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT choijookhuunarantsog apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hishikawayoshitaka apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT nanashimaatsushi apreliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT kaikengo preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hiyoshimasahide preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT imamuranaoya preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hamadatakeomi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT yanokoichi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT satoyuichiro preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT sakaetakehumi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT komimasanori preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT nakamuratakashi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT choijookhuunarantsog preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT hishikawayoshitaka preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis
AT nanashimaatsushi preliminarypathologicalevaluationofextracellularvolumefractionwithcontrastenhancedcomputedtomographyasanovelquantitativeparameterofpancreaticfibrosis